canventol
structure given in first source; inhibits tumor necrosis factor alpha release and protein isoprenylation
Also Known As:
2-isopropyl-4-isopropylidenecyclohex-2-ene-1-ol
Networked: 5
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Related Diseases
1. | Neoplasms (Cancer)
|
2. | Carcinogenesis
08/01/1993
- " A synthetic compound named canventol, 2-isopropyl-4-isopropylidencyclohex-2-ene-1-ol, inhibited tumor promotion of okadaic acid on mouse skin initiated with 7,12-dimethylbenz(a)anthracene in two-stage carcinogenesis experiments more strongly than sarcophytol A, isolated from a soft coral, although canventol has a simpler structure than sarcophytol A. " 08/15/1996
- " Mechanisms of cancer prevention were studied using structurally different cancer-preventive agents, sarcophytol A, canventol, (-)-epigallo-catechin gallate, and tamoxifen, based on our evidence that tumor necrosis factor alpha (TNF-alpha) acts as an endogenous tumor promoter relevant to human carcinogenesis. "
|
3. | Necrosis
|
|
Related Drugs and Biologics
Related Therapies and Procedures